Participation in COVID vaccine trials key to Black economic recovery

WASHINGTON » Vaccine trials need Black people. And the Black economic recovery needs a vaccine.

The economic downturn from COVID-19 has had a staggering financial impact on Blacks. Job losses from the pandemic have overwhelmingly affected low-wage, minority workers. Black men and women are among those taking the longest time to regain their employment.

Black Americans account for about 13% of the U.S. population but 24% of coronavirus deaths, the Pew Research Center reported in June.

But when I ask the Black folks

I know if they’re going to take a covid-19 vaccine, most without hesitation say, “No, I will not.”

They all reference the infamous Tuskegee syphilis study, which started in 1932 with the recruitment of 600 Black men. About half of the men in the initial study conducted by the U.S. Public Health Service had syphilis, but they weren’t given adequate treatment because the point of the experiment was to watch the progression of the venereal disease. A government panel later found that the men weren’t told the true purpose of the experiment.

Others point to the case of

Henrietta Lacks, a young Black woman whose cells were taken without her consent during a 1951 visit to Johns Hopkins Hospital in Baltimore. Researchers found that Lacks, who died from cervical cancer that same year, had extraordinary cells, which have since been reproduced countless times for medical research around the world.

There are also “long-standing inequities in health care access and outcomes for black Americans compared with other racial and ethnic groups,” pointed out the Pew report.

So, yes, Blacks have a legitimate distrust of the medical profession. Half of Blacks said they would not be willing to take a newly developed COVID-19 vaccine, according to a poll by Kaiser Family Foundation and ESPN’s The Undefeated.

But Freeman A. Hrabowski III, the president of the University of Maryland, Baltimore County (UMBC), and his wife, Jacqueline, want to change attitudes and save lives. The Hrabowskis, who are Black, volunteered for a Phase 3 clinical vaccine trial being conducted by the University of Maryland School of Medicine. They hope to serve as an example to show Blacks they can trust the science behind the rush to develop a covid-19 vaccine.

“Our Black friends are surprised and worried that we’re in this trial,” Freeman Hrabowski said in an interview. “And our attitude is very different from that. We have a chance to work for the public good and to help people in general and African Americans to understand that we’ve got to be a part of this process if we want to make sure that all of the challenges involving every population have been addressed as they look for a safe vaccine.”

The trial the Hrabowskis are volunteering for was co-developed by scientists at the biotech firm Moderna and the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health (NIH).